参考文献/References:
[1] Bovolini A,Garcia J,Andrade MA,et al.Metabolic syndrome pathophysiology and predisposingfactors[J].Int J Sports Med,2021,42(3):199-214.DOI:10.1055/a-1263-0898.
[2] Cruz-Jentoft AJ,Bahat G,Bauer J,et al.Writing group for the european working group on Sarcopenia in older People 2(EWGSOP2),and the extended group for EWGSOP2.Sarcopenia:revised European consensus on definition and diagnosis[J].Age Ageing,2019,48(1):16-31.DOI:10.1093/ageing/afy169.
[3] 杨蕾.中老年人肌肉减少症与代谢综合征的相关性及代谢组学研究[D].新疆:新疆医科大学,2020.DOI:10.27433/d.cnki.gxyku.2020.001020.
[4] Pirruccello-Straub M,Jackson J,Wawersik S,et al.Blocking extracellular activation of myostatin as a strategy for treating muscle wasting[J].Sci Rep,2018,8(1):2292.DOI:10.1038/s41598-018-20524-9.
[5] Omosule CL,Phillips CL.Deciphering myostatin's regulatory,metabolic,and developmental influence in skeletal diseases[J].Front Genet,2021,12:662908.DOI:10.3389/fgene.2021.662908.
[6] Rybalka E,Timpani CA,Debruin DA,et al.The failed clinical story of myostatin inhibitors against duchenne muscular dystrophy:exploring the biology behind the battle[J].Cells,2020,9(12):2657.DOI:10.3390/cells9122657.
[7] Liu HH,Mao HG,Dong XY,et al.Expression of MSTN gene and its correlation with pectoralis muscle fiber traits in the domestic pigeons(Columba livia)[J].Poult Sci,2019,98(11):5265-5271.DOI:10.3382/ps/pez399.
[8] Yang S,Li X,Liu X,et al.Parallel comparative proteomics and phosphoproteomics reveal that cattle myostatin regulates phosphorylation of key enzymes in glycogen metabolism and glycolysis pathway[J].Oncotarget,2018,9(13):11352-11370.DOI:10.18632/oncotarget.24250.
[9] Lee J,Kim DH,Lee K.Muscle hyperplasia in Japanese quail by single amino acid deletion in MSTN propeptide[J].Int J Mol Sci,2020,21(4):1504.DOI:10.3390/ijms21041504.
[10] Hu Z,Zhou L,He T.Potential effect of exercise in ameliorating insulin resistance at transcriptome level[J].J Sports Med Phys Fitness,2019,59(1):116-125.DOI:10.23736/S0022-4707.17.07862-8.
[11] Amor M,Itariu BK,Moreno-Viedma V,et al.Serum myostatin is upregulated in obesity and correlates with insulin resistance in humans[J].Exp Clin Endocrinol Diabetes,2019,127(8):550-556.DOI:10.1055/a-0641-5546.
[12] Tournadre A,Vial G,Capel F,et al.Sarcopenia[J].Joint Bone Spine,2019,86(3):309-314.DOI:10.1016/j.jbspin.2018.08.001.
[13] 柳杨青,汪艳芳.敲除MSTN基因可上调骨骼肌胰岛素信号通路并减轻2型DM小鼠胰岛素抵抗[J].中国病理生理杂志,2021,37(11):1957-1964.DOI:10.3969/j.issn.1000-4718.2021.11.005.
[14] Bonala S,Lokireddy S,McFarlane C,et al.Myostatin induces insulin resistance via casitas B-lineage lymphoma b(Cblb)-mediated degradation of insulin receptor substrate 1(IRS1)in response to high calorie diet intake[J].J Biol Chem,2016,291(27):14392.DOI:10.1074/jbc.A113.529925.
[15] Li B,Cui W,Yang J.Enhanced skeletal muscle growth in myostatin-deficient transgenic pigs had improved glucose uptake in stretozotocin-induced diabetes[J].Transgenic Res,2020,29(2):253-261.DOI:10.1007/s11248-020-00194-y.
[16] Yan H,Meng J,Zhang S,et al.Pretreatment of rAAV-mediated expression of myostatin propeptide lowers type 2 diabetes incidence in C57BL/6 mice on a high-fat diet[J].Hum Gene Ther,2019,30(5):661-671.DOI:10.1089/hum.2018.140.
[17] Zambon Azevedo V,Silaghi CA,Maurel T,et al.Impact of sarcopenia on the severity of the liver damage in patients with non-alcoholic fatty liver disease[J].Front Nutr,2022,8:774030.DOI:10.3389/fnut.2021.774030.
[18] Zarfeshani A,Ngo S,Sheppard AM.Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway-potential implications for nonalcoholic fatty liver disease[J].Clin Epigenetics,2014,6(1):27.DOI:10.1186/1868-7083-6-27.
[19] Verzola D,Milanesi S,Viazzi F,et al.Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy[J].Sci Rep,2020,10(1):6343.DOI:10.1038/s41598-020-62875-2.
[20] Butcher JT,Mintz JD,Larion S,et al.Increased muscle mass protects against hypertension and renal injury in obesity[J].J Am Heart Assoc,2018,7(16):e009358.DOI:10.1161/JAHA.118.009358.
[21] Chung JO,Park SY,Chung DJ,et al.Serum myostatin levels are positively associated with diabetic retinopathy in individuals with type 2 diabetes mellitus[J].J Diabetes Complications,2020,34(7):107592.DOI:10.1016/j.jdiacomp.2020.107592.
[22] Liu J,Wang Y,Lin L.Small molecules for fat combustion:targeting obesity[J].Acta Pharm Sin B,2019,9(2):220-236.DOI:10.1016/j.apsb.2018.09.007.
[23] 刘兰芳,徐晓阳,齐园圃.衰老对骨骼肌脂代谢的相关调控因子的影响[J].体育科技文献通报,2021,29(12):209-210.DOI:10.19379/j.cnki.issn.1005-0256.2021.12.062.
[24] Buehring B,Binkley N.Myostatin--the holy grail for muscle,bone,and fat?[J].Curr Osteoporos Rep,2013,11(4):407-414.DOI:10.1007/s11914-013-0160-5.
[25] Eilers W,Chambers D,Cleasby M,et al.Local myostatin inhibition improves skeletal muscle glucose uptake in insulin-resistant high-fat diet-fed mice[J].Am J Physiol Endocrinol Metab,2020,319(1):E163-E174.DOI:10.1152/ajpendo.00185.2019.
[26] 伏智亮,沈如玉,王绮绮,等.肌肉生长抑制素调控肌肉和脂肪组织代谢的研究进展[J].畜牧与兽医,2019,51(7):121-126.
相似文献/References:
[1]艾华,谢岚.Irisin与代谢性疾病的关系[J].国际内分泌代谢杂志,2014,(05):316.[doi:10.3760/cma.j.issn.1673-4157.2014.05.008]
Ai Hua,Xie Lan.Relationship between irisin and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(02):316.[doi:10.3760/cma.j.issn.1673-4157.2014.05.008]
[2]陈恺情,卜瑞芳.Irisin——可否让代谢性疾病治疗进入新时代[J].国际内分泌代谢杂志,2016,36(01):38.[doi:10.3760/cma.j.issn.1673-4157.2016.01.009]
Chen Kaiqing,Bu Ruifang..Could irisin lead the treatment of metabolic diseases into a new era?[J].International Journal of Endocrinology and Metabolism,2016,36(02):38.[doi:10.3760/cma.j.issn.1673-4157.2016.01.009]
[3]谢绍锋,黄莉吉,王昆,等.南京市城区40岁以上人群超重、肥胖流行
特点调查分析[J].国际内分泌代谢杂志,2016,36(03):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
Xie Shaofeng*,Huang Liji,Wang Kun,et al.Epidemiological investigation of overweight and obesity in population aged 40 years or older in Nanjing City[J].International Journal of Endocrinology and Metabolism,2016,36(02):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
[4]祝凌妃,杨震,秦利.肌肉因子与代谢性疾病[J].国际内分泌代谢杂志,2016,36(05):355.[doi:10.3760/cma.j.issn.1673-4157.2016.05.19]
Zhu Lingfei,Yang Zhen,Qin li.Myokines and metabolic disease[J].International Journal of Endocrinology and Metabolism,2016,36(02):355.[doi:10.3760/cma.j.issn.1673-4157.2016.05.19]
[5]项芬芬,张学梅,高英慧,等.p53与物质能量代谢的关系[J].国际内分泌代谢杂志,2017,37(04):262.
Xiang Fenfen*,Zhang Xuemei,Gao Yinghui,et al.Relationship between p53 and material, energy metabolism[J].International Journal of Endocrinology and Metabolism,2017,37(02):262.
[6]杨雪 相萍萍 陈国芳 刘超.IGF-1在代谢性疾病中的作用[J].国际内分泌代谢杂志,2018,38(01):33.[doi:10.3760/cma.j.issn.1673-4157.2018.01.009]
Yang Xue,Xiang Pingping,Chen Guofang,et al.Effects of IGF-1 in metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(02):33.[doi:10.3760/cma.j.issn.1673-4157.2018.01.009]
[7]杨雪 韦晓 杨婉薇 陈国芳 刘超.代谢组学在糖尿病研究中的应用[J].国际内分泌代谢杂志,2018,38(05):343.[doi:10.3760/cma.j.issn.1673-4157.2018.05.015]
Yang Xue,Wei Xiao,Yang Wanwei,et al.Application of metabonomics in diabetic research[J].International Journal of Endocrinology and Metabolism,2018,38(02):343.[doi:10.3760/cma.j.issn.1673-4157.2018.05.015]
[8]王佳蓓 陈风 刘莹 王涤非.Nur77与物质能量代谢的关系[J].国际内分泌代谢杂志,2019,39(01):49.[doi:10.3760/cma.j.issn.1673-4157.2019.01.012]
Wang Jiabei,Chen Feng,Liu Ying,et al.Relationship between Nur77 and meterial, energy metabolism[J].International Journal of Endocrinology and Metabolism,2019,39(02):49.[doi:10.3760/cma.j.issn.1673-4157.2019.01.012]
[9]王雪 朱惠娟 龚凤英.棕色脂肪因子与代谢性疾病[J].国际内分泌代谢杂志,2019,39(06):409.[doi:10.3760/cma.j.issn.1673-4157.2019.06.012]
Wang Xue,Zhu Huijuan,Gong Fengying.Relationship between brown adipocytokine and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2019,39(02):409.[doi:10.3760/cma.j.issn.1673-4157.2019.06.012]
[10]王鹏程,姜长涛.肠源神经酰胺与代谢性疾病[J].国际内分泌代谢杂志,2021,41(04):295.[doi:10.3760/cma.j.cn121383-20200610-06029]
Wang Pengcheng,Jiang Changtao..Relationship between intestinal ceramide and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2021,41(02):295.[doi:10.3760/cma.j.cn121383-20200610-06029]